# Intravenous Dexmedetomidine as a Perioperative Autonomic-Immune Neuromodulator

> **NCT07743853** · NA · NOT_YET_RECRUITING · sponsor: **Poznan University of Medical Sciences** · enrollment: 90 (estimated)

## Conditions studied

- Hip Osteoarthritis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Dexmedetomidine
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT07743853
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743853, "Intravenous Dexmedetomidine as a Perioperative Autonomic-Immune Neuromodulator". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*